Bayer moves forward on Teva integration

Published on: May 10, 2013

Bayer HealthCare reported May 10 that it is successfully integrating the recently acquired Teva Animal Health Inc. (Feedstuffs, Sept. 17, 2012) by beginning the process of introducing products to the U.S. market under the Bayer brand. This U.S. acquisition was the largest-ever for Bayer HealthCare's Animal Health Division, broadening the portfolio with complementary companion and food animal products, the announcement said.

The reintroduced products are primarily in the dermatology and supplement categories, Bayer noted, adding that over the next 12-18 months, additional products from the acquisition will continue to enter the U.S. market.

"We have worked diligently to incorporate these products into our portfolio and bring them back to market," said Dr. Dirk Ehle, global head of the Bayer HealthCare Animal Health Division. "This expansion of our business demonstrates both our commitment to our customers and our growing presence in the animal health field. With this latest acquisition, Bayer HealthCare is now active in most major therapeutic areas of the animal health field, with a strong portfolio to support the health of both farm and companion animals."

In 2012, Bayer HealthCare signed an agreement to acquire the U.S. animal health business based in St. Joseph, Mo. The acquisition reinforced the food animal franchise of Bayer HealthCare by providing a range of anti-infective solutions for livestock and introducing reproductive hormones to Bayer's product offerings. This transaction also strengthened Bayer HealthCare's companion animal franchise by expanding its portfolio with dermatological, pet wellness and nutraceutical products.